E-DRUG: Need for more research on treatment of tuberculosis
-----------------------------------------------------------
An important article highlights the urgent need for more clinical and
operational research of tuberculosis treatment
Lancet. 2004 Feb 7;363(9407):474-81.
Programmes and principles in treatment of multidrug-resistant tuberculosis.
Mukherjee JS, Rich ML, Socci AR, Joseph JK, Viru FA, Shin SS, Furin JJ,
Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ.
Available for free at: [repair URL!]
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-4BMSWPG-X&_co
v
erDate=02%2F07%2F2004&_alid=158760167&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=
4
886&_sort=d&view=c&_acct=C000014058&_version=1&_urlVersion=0&_userid=201547&
m
d5=e973d9470bfb7201631ef908c407c075
Anibal Sosa, MD
Director, International Program & Clinical Advisor
Alliance for the Prudent Use of Antibiotics (APUA)
75 Kneeland Street
Boston, MA 02111, USA
Tel: (617) 636-2709
Fax: (617) 636-3999
E-mail: anibal.sosa@tufts.edu
www.apua.org
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug